|
|
|
|
| LEADER |
01000caa a22002652 4500 |
| 001 |
WHO004341082 |
| 003 |
DE-627 |
| 005 |
20230425165431.0 |
| 007 |
cr uuu---uuuuu |
| 008 |
210507s2021 xx |||||o 00| ||eng c |
| 035 |
|
|
|a (DE-627)WHO004341082
|
| 035 |
|
|
|a (UBBS_Klinische_Studien_WHO)EUCTR2018-004117-40-NL
|
| 035 |
|
|
|a (UBBS_Klinische_Studien_WHO)MK-3475-641
|
| 035 |
|
|
|a (UBBS_Klinische_Studien_WHO)122753
|
| 035 |
|
|
|a (UBBS_Klinische_Studien_WHO)2018-004117-40-DE
|
| 040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
| 041 |
|
|
|a eng
|
| 245 |
1 |
0 |
|a Phase 3 Study of Pembrolizumab plus Enzalutamide in mCRPC
|b A Phase 3, Randomized, Double-blind Trial of Pembrolizumab (MK-3475) Plus Enzalutamide Versus Placebo Plus Enzalutamide in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC) (KEYNOTE-641)
|
| 264 |
|
1 |
|c 2021
|
| 336 |
|
|
|a Text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a Computermedien
|b c
|2 rdamedia
|
| 338 |
|
|
|a Online-Ressource
|b cr
|2 rdacarrier
|
| 500 |
|
|
|a WHO International Clinical Trials Registry Platform (https://www.who.int/ictrp/en/), First posted: 29-05-2019, Last updated: 2022-11-24
|
| 650 |
|
4 |
|a Medical Condition: Metastatic Castration-Resistant Prostate Cancer MedDRA version: 21.1Level: PTClassification code 10036909Term: Prostate cancer metastaticSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) MedDRA version: 21.1Level: LLTClassification code 10076506Term: Castration-resistant prostate cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps);Therapeutic area: Diseases [C] - Cancer [C04]
|
| 650 |
|
4 |
|a Study Type: Interventional
|
| 650 |
|
4 |
|a Phase: Phase 3
|
| 650 |
|
4 |
|a Recruitment Status: Authorised-recruitment may be ongoing or finished
|
| 650 |
|
4 |
|a 610
|
| 773 |
0 |
8 |
|i Enthalten in
|t WHO International Clinical Trials Registry Platform
|g (2021) vom: 08. Nov.
|
| 773 |
1 |
8 |
|g year:2021
|g day:08
|g month:11
|
| 856 |
4 |
0 |
|u https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2018-004117-40
|z kostenfrei
|3 Volltext
|
| 912 |
|
|
|a GBV_CTG
|
| 912 |
|
|
|a SSG-OLC-PHA
|
| 951 |
|
|
|a AR
|
| 952 |
|
|
|j 2021
|b 08
|c 11
|
Klinische Studie